What X4 Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 1 | 1 |
| Sells | 3 | 5 |
| Total trades | 4 | 6 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 4,600 | 4,600 |
| Disposed | 83,779 | 109,283 |
| Net activity | −79,179 | −104,683 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Craig Adam R | Executive Chairman | Oct 16 | Open-market buy · P | +4,600 | $2.58 | +$11.9K | 333,251 |
| Kirske David | Chief Financial Officer | Oct 01 | Open-market sale · S | −11,767 | $2.86 | −$33.7K | 155,983 |
| Craig Adam R | Executive Chairman | Aug 12 | Open-market sale · S | −47,436 | $4.44 | −$211K | 328,651 |
| Volpone John | President | Aug 12 | Open-market sale · S | −24,576 | $4.44 | −$109K | 265,305 |
| Kirske David | Chief Financial Officer | Jun 30 | Open-market sale · S | −8,543 | $4.26 | −$36.4K | 167,750 |
| Kirske David | Chief Financial Officer | May 12 | Open-market sale · S | −16,961 | $4.29 | −$72.8K | 176,293 |
| Craig Adam R | Executive Chairman | Oct 23 | Open-market buy · P | +86,206 | $2.90 | +$250K | 376,087 |
| Volpone John | President | Aug 14 | Grant / award · A | +289,881 | — | — | 289,881 |
| Craig Adam R | Executive Chairman | Aug 14 | Grant / award · A | +289,881 | — | — | 289,881 |
| Kirske David | Chief Financial Officer | Aug 14 | Grant / award · A | +193,254 | — | — | 193,254 |
| Wyzga Michael S | Director | Jun 09 | Grant / award · A | +1,500 | — | — | 5,555 |
| Mcgirr David W J | Director | Jun 09 | Grant / award · A | +1,500 | — | — | 4,722 |
| Woods Keith | Director | Jun 09 | Grant / award · A | +1,500 | — | — | 6,000 |
| Bridger Gary | Director | Jun 09 | Grant / award · A | +1,500 | — | — | 4,722 |
| de Craecker Francoise | Director | Jun 09 | Grant / award · A | +1,500 | — | — | 4,722 |
| Stewart Murray | Director | Jun 09 | Grant / award · A | +1,500 | — | — | 7,883 |
| Thoren Natasha Fay | Chief Legal Officer | May 20 | Grant / award · A | +3,333 | — | — | 9,462 |
| Baldry Mark | Chief Commercial Officer | May 16 | Grant / award · A | +1,032 | $2.48 | +$2.56K | 25,337 |
| Baldry Mark | Chief Commercial Officer | Feb 12 | Grant / award · A | +600,000 | — | — | 729,173 |
| Ragan Paula | President and CEO | Feb 12 | Grant / award · A | +2,250,000 | — | — | 3,337,386 |
Loading...
